Cancer Genetics to raise $15M in secondary offering; St. Jude critic acknowledges Durata fix;

@FierceMedDev: Don't forget to nominate! We're looking for 15 of the fiercest device and diagnostics developers. Info | Follow @FierceMedDev

@DamianFierce: Study: Medical devices spur complications for kids. More | Follow @DamianFierce

@MarkHFierce: Teleflex has long pursued M&A involving small startups with promising tech. This time, it's Israel's Eon Surgical. Article | Follow @MarkHFierce

 @MichaelGFierce: BioFire scores CE mark for sepsis blood Dx. Item | Follow @MichaelGFierce

> One of the doctors who first flagged problems with St. Jude Medical's ($STJ) Riata lead is now saying the company has righted the issue with Durata. News

> Cancer Genetics has filed to raise $15 million from a secondary offering. Story (sub. req.)

> San Antonio's med tech sector is poised for some major growth, the San Antonio Business Journal reports. Item

> University of Washington spinout Cardiac Insight won FDA clearance to start selling a tiny atrial fibrillation-monitoring device. Story

> Qiagen ($QGEN) is expanding its sequencing capabilities, planning to launch another 20 validated gene panels. More

> Switzerland's Diagnoplex has raised about $1.4 million to secure a CE mark for its Colox colon cancer diagnostic. Item

> In a blog post, the FDA uses the example of Synthes' illegal marketing of its Norian XR bone cement to illustrate the role of the agency's Office of Criminal Investigation. Article

> A University of Buffalo researcher will begin work on developing an ultrasonic intra-body communication network for bionic implants. Story

Biotech News

@FierceBiotech: From IMS Health scoops up Incential Software. Report | Follow @FierceBiotech

@RyanMFierce: Sanofi seeks compelling case for next-generation Lantus in diabetes war. Article | Follow @RyanMFierce

@EmilyMFierce: Spinal muscular atrophy patients could benefit from new drug. Story | Follow @EmilyMFierce

> Royalty Pharma drops 'game-changer' on Elan with up to $8B bid. More

> Canada's Medicago reports positive early data for H7N9 vaccine. Story

> Pharma giant AbbVie backs biotech startup working on oral bowel drug. News

Pharma News

@FiercePharma: Mini-Pfizer? Endo to cut 700 jobs, review asset sales in refocus on core pharma biz. Yesterday's story | Follow @FiercePharma

@EricPFierce: Is Teva and its generic of Avandia the big winner in today's vote? More | Follow @EricPFierce

@CarlyHFierce: The FDA advisory panel reached a verdict on Avandia yesterday. How would you have voted? Story | Follow @CarlyHFierce

> Battle of weight-loss drugs begins as Arena launches Belviq next week. Article

> Sanofi uses multi-pronged strategy to defend its place in diabetes market. Story

> Reuters: Forest, Icahn negotiate to avoid 3rd proxy battle. More

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.